Information  X 
Enter a valid email address

xG Technology Inc. (XGT)

  Print   

Friday 15 November, 2013

xG Technology Inc.

Quarterly Report

RNS Number : 1425T
xG Technology Inc.
15 November 2013
 



November 15, 2013

 

 

xG Technology, Inc.

 ("xG", "xG Technology" or the "Company")

 

Quarterly Report for the Quarter ended September 30, 2013

 

xG Technology, a developer of wireless communications and spectrum sharing technologies, announces its quarterly results for the three months ended September 30, 2013 and the nine months ended September 30, 2013. These results are set out in a 10-Q filing, as set out below, which has been prepared in accordance with U.S. GAAP and filed with the U.S. Securities and Exchange Commission.

 

END

Contacts

xG Technology, Inc.

www.xgtechnology.com

John Coleman, Chief Executive Officer

+1 212 651 4219

Roger Branton, Chief Financial Officer

+1 212 651 4219

James Woodyatt, Investor Relations

+1 954 572 0395



Allenby Capital Limited

www.allenbycapital.com

(Nominated Adviser and Joint Broker)


Nick Naylor

+44 20 3328 5656

Mark Connelly

+44 20 3328 5656



First Columbus LLP (Joint Broker)

www.first-columbus.com

Chris Crawford

+44 20 3002 2070



Fusion PR (Media and Analyst Relations)

www.fusionpr.com

 

 

David Worthington

+1 212 651 4200



LHA (Investor Relations)

 

www.lhai.com

 

Jody Burfening/Carolyn Capaccio

 

+1 (212) 838-3777

 

 

ABOUT XG TECHNOLOGY

xG Technology develops a broad portfolio of intellectual property to make wireless networks more intelligent, accessible, affordable and reliable. The company has created xMax, a patented all-IP cognitive radio technology that enables spectrum sharing. xMax can solve the crisis facing the wireless industry caused by data-hungry devices and applications that are straining network capacity. It eliminates the need to acquire scarce and expensive licensed spectrum, thus lowering the total cost of ownership for wireless broadband access. xG's goal is to help wireless broadband network operators make more efficient use of their spectrum allocations and to create new opportunities for innovation in unlicensed spectrum. The xMax cognitive radio system incorporates advanced optimizing technologies that include spectrum sharing, interference mitigation and self-organizing networks. xG offers solutions for numerous industries worldwide, including urban and rural wireless broadband, utilities, defense, emergency response and public safety.

Based in Sarasota, Florida, xG has over 60 U.S. and over 130 international patents and pending patent applications, and its technology is available for licensing in both domestic and foreign markets. xG is a publicly traded company listed on the NASDAQ Capital Market and on the London Stock Exchange's Alternative Investment Market (AIM). On the NASDAQ, xG common stock is traded under the symbol XGTI and xG warrants are traded under the symbol XGTIW. On the AIM, xG's unrestricted shares trade under the stock symbol XGTU.L and xG's restricted 'Reg S' shares trade under the stock symbol XGT.L.

For more information, please visit www.xgtechnology.com .

 

Cautionary Statement Regarding Forward Looking Statements

 

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties.  These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to xG Technology, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

 

 

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington , D.C. 20549

 

FORM 10-Q

 

(Mark One)

x

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2013

 

or

 

¨

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________to _______________.

 

Commission File Number: 333-187094

 

xG Technology, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware  


20-585-6795

(State or other jurisdiction of incorporation or
organization) 


(I.R.S. Employer Identification No.)

  

240 S. Pineapple Avenue, Suite 701

Sarasota , FL 34236

(Address of principal executive offices) (Zip Code)

 

(941) 953-9035 

(Registrant's telephone number, including area code)

 

n/a

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x     No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x   No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ¨

Accelerated filer ¨

Non-accelerated filer  ¨ (Do not check if a smaller reporting company)

Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨No x

 

The number of shares of the Registrant's common stock outstanding as of November 13, 2013 is 12,645,138.

 

 

 

 

xG TECHNOLOGY, INC. 

QUARTERLY REPORT ON FORM 10-Q

For the quarter ended September 30, 2013

 


Page
Number



PART I: FINANCIAL INFORMATION

1



Item 1. Financial Statements

1



Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

17



Item 3. Quantitative and Qualitative Disclosures About Market Risk

24



Item 4. Controls and Procedures

24



PART II. OTHER INFORMATION

25



Item 1. Legal Proceedings

25



Item 1A. Risk Factors

25



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

25



Item 3. Defaults Upon Senior Securities

25



Item 4. Mine Safety Disclosures

25



Item 5. Other Information

25



Item 6. Exhibits

26



SIGNATURES

27

 

 

 

 

PART I: FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Index to Financial Statements

 

Unaudited Condensed Balance Sheets as of September 30, 2013 and December 31, 2012

2



Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2013 and 2012

3



Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2013 and 2012

4



Notes to Condensed Financial Statements

5

 

The Company's unaudited condensed financial statements for the nine months ended September 30, 2013 and for comparable periods in the prior year are included below. The financial statements should be read in conjunction with the notes to financial statements that follow.

 

 


1




 

 

 

 

 

Table of Contents

 

xG TECHNOLOGY, INC.
UNAUDITED CONDENSED BALANCE SHEETS
(IN THOUSANDS EXCEPT PER SHARE DATA)

 


September 30, 2013



December 31, 2012


ASSETS








Current assets








Cash

$

2,558



$

271


Inventory


1,038




-


Prepaid expenses and other current assets


30




16


Total current assets


3,626




287


Property and equipment, net


1,569




1,725


Intangible assets, net


19,022




17,608


Total assets

$

24,217



$

19,620


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)








Current liabilities








Accounts payable

$

978



$

655


Accrued expenses


1,195




754


Accrued bonuses


2,633




2,633


Accrued interest and fees to related parties


87




1,169


Due to related party


1,326




1,098


Convertible notes payable to related party


-




17,198


Total current liabilities


6,219




23,507


Convertible notes payable to related party


2,000




2,000


Total liabilities


8,219




25,507


Commitments








Stockholders' equity (deficit)








Series A Convertible Preferred Stock - $0.01 par value per share:








10,000,000 and 25,000,000 shares authorized, none issued or
    outstanding as of September 30, 2013 and December 31, 2012


-




-


Common stock - $0.00001 par value, 300,000,000 and 250,000,000 shares
    authorized at September 30, 2013 and December 31, 2012, respectively;
    12,647,281 and 6,041,946 shares issued at September 30, 2013 and
    December 31, 2012, respectively


-

*



-

*

Additional paid in capital


163,809




118,247


Accumulated deficit


(147,789)




(124,112)


Treasury stock, at cost - 2,284 shares at September 30, 2013 and
    December 31, 2012, respectively


(22)




(22)


Total stockholders' equity (deficit)


15,998




(5,887)


Total liabilities and stockholders' equity (deficit)

$

24,217



$

19,620


 

* Less than $1

 

The accompanying notes are an integral part of these statements.

 

 


2




 

 

 

 

Table of Contents

 

xG TECHNOLOGY, INC.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
(IN THOUSANDS EXCEPT NET LOSS PER SHARE DATA)

 



For the Three Months Ended


For the Nine Months Ended




September 30,


September 30,




2013


2012


2013


2012


Revenue


$

33


$

-


$

33


$

-


Cost of revenue and operating expenses














Cost of components and personnel



1



-



1



-


General and administrative expenses



1,936



1,269



4,442



3,909


Development



1,776



1,164



4,775



3,063


Stock based compensation



201



151



537



259


Amortization and depreciation



442



513



1,312



1,540


Total cost of revenue and operating expenses



4,356



3,097



11,067



8,771


Loss from operations



(4,323)



(3,097)



(11,034)



(8,771)


Other




























Inducement expense



(391)



-



(391)



-


Interest expense, net



(1,146)



(152)



(2,184)



(346)


Other expense



(10,068)



-



(10,068)



-


Total other income (expense)



(11,605)



(152)



(12,643)



(346)


Loss before income tax provision



(15,928)



(3,249)



(23,677)



(9,117)


Income tax provision



-



-



-



-


Net loss


$

(15,928)


$

(3,249)


$

(23,677)


$

(9,117)
















Basic and diluted net loss per share


$

(1.70)


$

(0.54)


$

(3.11)


$

(1.51)


Weighted average number of shares outstanding basic and diluted



9,365



6,035



7,623



6,028


 

 

 

  The accompanying notes are an integral part of these statements.

 

 


3




 

 

 

 

 

Table of Contents

 

xG TECHNOLOGY, INC.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

 



Nine Months Ended September 30,




2013


2012


Cash flows from operating activities








Net loss


$

(23,677)


$

(9,117)


Adjustments to reconcile net loss to net cash used in operating activities








Stock based compensation



537



259


Share-based consulting and other services



35



158


Depreciation and amortization



1,312



1,540


Accretion of financing instruments



176



-


Amounts paid by affiliate on behalf of xG



-



1,339


Inducement expense



391



-


Other expense



10,068



-


Non-cash interest expense



601



-


Changes in assets and liabilities








Inventory



(1,038)



-


Other current assets



(340)



12


Accounts payable



323



87


Accrued expenses



223



141


Accrued interest and fees



1,907



717


Due to related party



1,241



631


Net cash used in operating activities



(8,241)



(4,233)


Cash flows from investing activities








Capital expenditures for property and equipment



(110)



(297)


Capitalization of intangible assets



(2,459)



(3,377)


Net cash used in investing activities



(2,569)



(3,674)


Cash flows from financing activities








Proceeds from convertible notes payable to related party



450



7,526


Proceeds from convertible bridge loan payable ($2,727 to related party)



4,994



-


Repayment of convertible bridge loan payable



(125)



-


Purchase of treasury stock






(12)


Proceeds from exercise of options



-



6


Proceeds from issuance of common stock



7,778



400


Net cash provided by financing activities



13,097



7,920


Net increase in cash



2,287



13


Cash, beginning of period



271



133


Cash, end of period


$

2,558


$

146


Supplemental cash flow disclosures of investing and financing activities








Conversion of notes payable


$

15,000


$

-


Conversion of convertible bridge loan payable including interest and fees



9,023



-


Interest and fees refinanced under the bridge loan



5,408



-


Due to related party refinanced under the bridge loan



1,393



-


Related Party amount refinanced under the bridge loan



1,013



-


Stock issued as payment for interest on convertible notes



90



90


 

 

 

The accompanying notes are an integral part of these statements.

 

 


4




 

 

 

 

 

 

 

 

Table of Contents  

 

xG TECHNOLOGY, INC.
NOTES TO THE FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2013 AND DECEMBER 31, 2012 AND FOR THE
THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2013 AND 2012
(Unaudited)

 

 

 

 

 

 NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

 Description of Business

xG Technology, Inc. (the "Company") is a Delaware corporation that has developed a broad portfolio of innovative intellectual property that we believe will enhance wireless communications. The Company's intellectual property is embedded in proprietary software algorithms designed to offer cognitive interference mitigation and spectrum access solutions to organizations in a wide variety of industries, including national defense and rural broadband, which represent the primary vertical markets that the Company is initially targeting.

 

 

 

Basis of Presentation

The accompanying unaudited financial statements were prepared using generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by generally accepted accounting principles for annual financial statements and should be read together with the 2012 Financial Statements as filed on the Company's recent Registration Statement on Form S-1, declared effective by the U.S. Securities and Exchange Commission on July 18, 2013.

 

 

The preparation of financial statements in conformity with these accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and the reported amounts of expenses during the reported period. Ultimate results could differ from the estimates of management.

 

In the opinion of management, the unaudited financial statements included herein contain all adjustments necessary to present fairly the Company's financial position as of September 30, 2013 and the results of its operations and cash flows for the three and nine months ended September 30, 2013 and 2012. Such adjustments are of a normal recurring nature. The results of operations for the three and nine months ended September 30, 2013 may not be indicative of results for the full year.

 

 

 

Cash and Cash Equivalents

The Company considers all highly liquid instruments, with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents are stated at costs and consist of bank deposits.

 

 

 

Revenue Recognition

Revenues from installation, management and consulting, time-and-materials service contracts is recognized at the time the service is performed. License revenue is recognized over the period of the term of the license.

 

 

 

 Property and Equipment

Property, plant, and equipment are presented at cost at the date of acquisition. Depreciation is computed using the straight-line method over estimated useful asset lives, which range from three to seven years commencing the month following the purchase.

 

 


5




 

 

Table of Contents

 

NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  (continued)

 

The cost of maintenance and repairs is charged to expense in the period incurred. Expenditures that increase the useful lives of assets are capitalized and depreciated over the remaining useful lives of the assets. When items are retired or disposed of, the cost and accumulated depreciation are removed from the accounts and any gain or loss is included in operations.

 

 

 

Inventory

Inventories are valued at the lower of cost or net realizable value determined on first-in-first out ("FIFO") basis. Net realizable value represents the estimated selling price less all estimated costs of completion and costs to be incurred in marketing, selling and distribution. Costs in inventory are comprised of direct materials. The Company maintains a reserve for obsolescence and slow moving, defective or obsolete items as deemed necessary.

 

 

 

Long-Lived Assets

The Company's long-lived assets are reviewed for impairment in accordance with the guidance of ASC 360-10, " Property, Plant, and Equipment ", whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. During the nine months ended September 30, 2013, no impairment losses were identified or recorded.

 

 

 

Income Taxes

Income taxes are accounted for under the asset and liability method as stipulated by ASC 740, "Accounting for Income Taxes" . Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities or a change in tax rate is recognized in operations in the period that includes the enactment date. Deferred tax assets are reduced to estimated amounts to be realized by the use of the valuation allowance. A valuation allowance is applied when in management's view it is more likely than not (50%) that such deferred tax will not be utilized.

 

ASC 740 provides interpretative guidance for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In the unlikely event that an uncertain tax position exists in which the Company could incur income taxes, the Company would evaluate whether there is a probability that the uncertain tax position taken would be sustained upon examination by the taxing authorities. A liability for uncertain tax positions would then be recorded if the Company determined it is more likely than not that a position would not be sustained upon examination or if a payment would have to be made to a taxing authority and the amount is reasonably estimable.

 

As of September 30, 2013, the Company does not believe any uncertain tax positions exist that would result in the Company having a liability to the taxing authorities. The Company's policy is to classify interest and penalties related to unrecognized tax benefits, if and when required, as part of interest expense and general and administrative expense, respectively, in the consolidated statement of operations. The Company's tax returns for the years ended 2010 through 2012 are subject to examination by the federal and state tax authorities.

 

 

 


6




 

 

Table of Contents

 

NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  (continued)

 

 

Fair Value Measurements

The Company follows the provisions of ASC 820, " Fair Value Measurements and Disclosures. " ASC 820 defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and enhances disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value, must maximize the use of observable inputs and minimize the use of unobservable inputs.

 

This standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. The Company's assessment of the significance of a particular input to the fair value measurements requires judgment, and may affect the valuation of the assets and liabilities being measured and their placement within the fair value hierarchy.

 

• Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

• Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

• Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

 

 

Financial Instruments

The Company's short-term financial instruments consist primarily of cash, inventory, accounts payable and accrued expenses. The carrying amount of debt, approximates fair value because current interest rates available to the Company for debt with similar terms and maturities are substantially the same. The other aforementioned financial instruments approximate fair value due to their short-term maturities.

 

 

 

Accounting for Stock-based Compensation

The Company follows ASC 718, " Compensation - Stock Compensation ", in accounting for its stock based compensation. This standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period.

 

The Company accounts for transactions in which services are received in exchange for equity instruments based on the fair value of such services received from non-employees, in accordance with ASC 505-50 " Equity Based Payments to Non-employees ".

 

 

 


7




 

 

Table of Contents

 

NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

 

Concentration of Risk

The Company does not have any off-balance-sheet concentrations of credit risk. The Company expects cash to be the single asset most likely to subject the Company to concentration of credit risk. The Company's policy is to maintain its cash with high credit quality financial institutions to limit its risk of loss exposure.

 

As of September 30, 2013, the Company maintained its cash in two financial institutions. During the year, the Company had cash balances in excess of the Federally insured limits of $250,000. The funds are on deposit with Wells Fargo Bank, N.A. Consequently, the Company does not believe that there is a significant risk having these balances in one financial institution. The Company has not experienced any losses in its bank accounts through September 30, 2013.

 

 

 

Intangible Assets

Software costs incurred in the research and development of software for sale to others as a separate product or embedded in a product and sold as part of the product as a whole are charged to expense until technological feasibility is established. Once established, software costs are capitalized and recorded as an intangible asset. The capitalized costs are amortized on a straight-line basis over five years, beginning when the products are offered for sale.

 

Management is required to use its judgment in determining whether capitalized software costs meet the criteria for immediate expense or capitalization, in accordance with Generally Accepted Accounting Principles (''GAAP''). The unamortized capitalized costs of a computer software product are compared to the net realizable value of that product and any excess is written-off.

 

The Company's proprietary software solutions operate in a fast changing industry that may generate unknown methods of detecting and monitoring disturbances that could render our technology inferior, resulting in the Company's results of operations being materially adversely affected. The Company does, however, closely monitor trends and changes in technology and customer demand that could adversely impact its competitiveness and overall success. It is reasonably possible that those estimates of anticipated future gross revenues, the remaining estimated economic life of the product, or both will be reduced significantly in the near term due to competitive pressures. As a result, the carrying amount of the capitalized software costs for our products may be reduced materially in the near term.

 

Costs incurred for product enhancements are charged to expense as research and development until the technological feasibility of the enhancement has been established. These enhancements are amortized on a straight line basis over the useful life of the product enhancement which is currently estimated to be five years beginning when the enhancements are integrated into the products that are offered for sale.

 

The Company's software is inherently complex and may contain defects and errors that are only detectable when the products are in use. Such defects or errors could have a serious impact on our end customers, which could damage our reputation, harm our customer relationships and expose us to liability. Defects in our software could adversely affect our ability and that of our customers to ship products on a timely basis as well as customer or licensee demand for our products. Any such delays or declines in demand could reduce our revenues and harm our ability to achieve or sustain desired levels of profitability. The Company and their customers may also experience component or software failures or defects that could require significant product recalls, rework and/or repairs that are not covered by warranty reserves. The Company has entered into certain customer agreements that contain conditions including but not limited to Federal Communications Commission ("FCC") authorization of our products. On September 5, 2013, the xMod went through additional FCC required testing, receiving certification. We received FCC equipment authorization for the xVM on September 24, 2013. The xVM is a vehicular mounted xMod. On September 26, 2013, the Company received a FCC grant of certification for the xAP. This completes all required FCC testing needed for xMax cognitive radio products. The Company's intellectual property is embedded in proprietary software algorithms that offer cognitive spectrum access and interference mitigation solutions.

 

Patents and licenses are measured initially at purchase cost and are amortized on a straight line basis over their useful lives which range between 18.5 to 20 years.

 

 

 

 

 

 

 


8




 

 

 

 

 

 

Table of Contents

 

 NOTE 2 - GOING CONCERN

 

The financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of the Company as a going concern. As of September 30, 2013, the Company had negative working capital of approximately $ 2,593,000 and an accumulated deficit of approximately $ 147,789,000 . This and other factors raise substantial doubt about the Company's ability to continue as a going concern.

 

On July 24, 2013, the Company closed its initial public offering for net proceeds to the Company after deducting underwriter discounts and offering expenses of $ 6,750,673 . On August 19, 2013, the Company closed an over-allotment option for net proceeds to the Company, after deducting underwriter discounts, of $ 1,027,349 . The Company believes that additional funding will be required to finance operations over the next twelve months in order to continue developing our product portfolio and commercialize our products for sale. As of September 30, 2013, the Company has a total backlog of $ 35,400,000 . On September 26, 2013, the company received the last remaining FCC testing needed for xMax cognitive radio products to be available for sale. The Company currently estimates that it will begin to fulfill orders associated with its backlog in the fourth quarter of 2013. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital and to fulfill its existing backlog. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern .

 

 

 

 

 

 

 

 NOTE 3 - INVENTORY

 

 Inventories included in the accompanying condensed balance sheet are stated at the lower of cost or market as summarized below:

 

 




September 30,



December 31,





2013



2012


Raw materials consisting of purchased parts, components and supplies


$

933,000


$

-


Finished goods



105,000



-










Total Inventory


$

1,038,000


$

-


 

 

 

 

 

 

 

 

 NOTE 4 - PROPERTY AND EQUIPMENT

 

 

 

 Property and equipment consist of the following:

 



Useful Life



September 30, 2013



December 31, 2012


Cost:










Furniture and equipment


3 - 7 years


$

2,080,000


$

1,970,000


Hardware


4 - 5 years



2,486,000



2,486,000







4,566,000



4,456,000


Accumulated depreciation:





(2,997,000)



(2,731,000)


Property and equipment, net




$

1,569,000


$

1,725,000


 

 

 

Depreciation expense amounted to approximately $ 266,000 and $ 490,000 for the nine months ended September 30, 2013 and 2012, respectively.

 

 

 

 

 


9




 

 

 

 

 

Table of Contents

 

 NOTE 5 - INTANGIBLE ASSETS

 

 

Intangible assets consist of the following:

 



Software Development Costs


Patents & Licenses


Total




Costs


A.A.


Cost


A.A.




Balance as of December 31, 2012


$

12,226,000


$

(1,261,000)


$

12,272,000


$

(5,629,000)


$

17,608,000


Additions



2,417,000



-



42,000



-



2,459,000


Impairments



-



-



-



-



-


Amortization



-



(580,000)



-



(465,000)



(1,045,000)


Balance as of September 30, 2013


$

14,643,000


$

(1,841,000)


$

12,314,000


$

(6,094,000)


$

19,022,000


 

 

 

Software Development Costs

On September 26, 2013, the Company received the last remaining certification from the FCC needed for the xMax cognitive radio products. The xMax cognitive radio products include the xAP, xMod, xVM and xMSC. Beginning on September 30, 2013, Management determined that the xMax cognitive radio products were available for sale and these products will be amortized on a straight line basis over an estimated life of five years. Also included in capitalized software is $ 3.9 million of software development costs related to the BSN 250 base station and the TX70 handset which allowed the Company to offer for sale its voice and spectrum access solutions during 2011 as evidenced by the sales to the U.S. Army.

 

During the nine months ended September 30, 2013 and 2012, the Company recognized amortization of software development costs available for sale of $ 0.6 million and $ 0.5 million, respectively.

 

Patents & Licenses

At September 30, 2013 the Company has capitalized a total of $ 12.3 million of patents & licenses. Included in the capitalized costs is $ 12.0 million of costs associated with patents and licenses that have been filed. Also included in the capitalized costs is $ 0.3 million of costs associated with provisional patents and pending applications which have not yet been filed.

 

The Company amortizes patents and licenses that have been filed over their useful lives which range between 18.5 to 20 years. The costs of provisional patents and pending applications is not amortized until the patent is filed and is reviewed each reporting period to determine if it is likely that the patent will be successfully filed. The Company recognized $ 0.5 million of amortization expense related to patents and licenses for the nine months ended September 30, 2013 and 2012.

 

 

Estimated amortization expense for the twelve-month periods ended September 30 as follows:

 

2014


$

3,581,000


2015



3,581,000


2016



3,450,000


2017



2,795,000


2018 and thereafter



5,366,000




$

18,773,000


 

 

 

 

 

 

 

 

 

 NOTE 6 - CONVERTIBLE NOTES PAYABLE

 

May 2011 Convertible Note

On May 19, 2011, the Company entered into a convertible promissory note (the "May 2011 Convertible Note") whereby the Company borrowed principal advances in the amount of up to $ 15 million with MB Technology Holdings, LLC (''MBTH'') (subject to increase by mutual agreement). The loan was payable on final maturity, May 19, 2016 , or earlier demand, and was convertible, at MBTH's option, into shares of the Company at a price of $ 26.25 per share. Interest was payable semi-annually in cash or shares, at the Company's option, at the rate of 8 % per year. Additionally, a facility fee of 2 % was payable by the Company at maturity. The loan facility was secured against substantially all of the assets of the Company.

 

As of December 31, 2012, the Company had drawn down $ 17.2 million of principal balance under the May 2011 Convertible Note. The Company drew down an additional $ 450,000 on the May 2011 Convertible Note with MBTH from January 1, 2013 through January 16, 2013 to finance operating activities of the Company. As of December 31, 2012 the Company had accrued interest and fees under the May 2011 Convertible Note of $ 1.1 million and the Company accrued additional interest and fees of $ 266,000 from January 1, 2013 through January 16, 2013.

 

 


10




 

 

Table of Contents

 

NOTE 6 - CONVERTIBLE NOTES PAYABLE (continued)

 

On January 16, 2013, the Company entered into several agreements as part of negotiations to induce MBTH to convert $ 15.0 million of the principal balance under the May 2011 Convertible Loan. As part of these negotiations, the Company entered into Amendment Number 1 to the May 2011 Convertible Loan Facility whereby the Company modified the conversion price on the May 2011 Convertible Loan from $26.25 to $13.30 (the "Modified Strike Price"). In addition, the Company agreed to issue MBTH 142,857 common shares upon the exercise in full of MBTH's conversion rights, termination of the May 2011 Shareholder Loan and the discharge of all MBTH's collateral over the Company's assets .

 

The Company agreed to modify the exercise price on two options representing 571,428 underlying common shares granted to MBTH under the February 2011 Convertible Loan from $17.50 with respect to an option for 285,714 underlying shares and $35.00 with respect to an option for 285,714 common shares to the Modified Strike Price of $13.30. The Company also agreed to compensate MBTH for funding and other costs assumed by MBTH by issuing MBTH 16,474 common shares at the Modified Strike Price for the difference between the interest rate of 8% that the Company owed to MBTH under the May 2011 Convertible Loan and the interest rate of 9.5% that MBTH pays to investors for monies raised by MBTH.

 

The Company agreed to grant MBTH a warrant to subscribe for 42,857 common shares (the "42,857 Warrant") with an exercise price of $0.35 per share. The 42,857 Warrant is contingent upon shareholders of MBTH electing to exercise a warrant issued to them by MBTH (the "MBTH Warrant") in xG Technology, Inc. common shares. If the MBTH shareholder elect not to exercise the MBTH Warrant or they elect to exercise a portion or all of the MBTH Warrant into shares of MBTH, a proportionate number of common shares under the 42,857 Warrant will be issued to MBTH.

 

The Company agreed to award MBTH an option for 142,857 common shares with an exercise price equal to $8.75 per share.

 

On January 16, 2013, in consideration of the terms above, MBTH gave the Company notice to its intention to exercise the conversion rights on the 2011 Convertible Loan. On March 26, 2013, the Company issued 1,127,819 common shares to MBTH in consideration of the conversion rights under the May 2011 Convertible Note to convert the principal balance of $ 15.0 million principal balance into common shares at $13.30 per share, and 142,857 common shares were issued for the discharge of MBTH's collateral over the Company's assets. The additional consideration described above was considered an induced conversion of the 2011 Convertible Loan. The Company recorded debt inducement for the differential in the value of securities issued to the debt holder under the original terms compared to the value of securities issued to the debt holder under the amended terms. Additionally, the modification of options were accounted for as debt inducement based upon the valuation of the option immediately prior to the amendment compared to the value of the option with the amended terms. As a result of the modified terms, the Company recorded debt inducement of $ 14.1 million during the nine months ended September 30, 2013. The inducement was recorded as a reduction to additional paid in capital as MBTH is a related party.

 

The Company agreed to award MBTH a 3 % cash success fee if MBTH arranges additional financing for the Company by a third party (other than the Bridge Loan as defined below) or arranges a merger, consolidation or sale by the Company of substantially all of the assets to a third party.

 

Bridge Loan

Under a subscription agreement and convertible promissory note (the "Bridge Loan") between the Company and MBTH dated January 16, 2013, MBTH committed to advance to the Company $ 5 million as part of a new convertible bridge loan for up to an aggregate of $ 10 million. The Bridge Loan was issued to refinance principal advances under the May 2011 Convertible Loan in excess of $ 15 million, all accrued interest and fees under the May 2011 Convertible Loan and for general corporate purposes including; additional working capital and product development. On January 16, 2013, the Company refinanced principal of $ 2,648,000 and accrued interest of fees of $ 1,393,000 under the May 2011 Convertible Note for a beginning principal balance of $ 4,041,000 under the Bridge Loan.

 

The Bridge Loan is for a term of one year and is convertible, at each loan note holder's option, into common shares at any time prior to final maturity at $ 5.225 (95% of $ 5.50 , the price of the Company's initial public offering completed on July 24, 2013). Interest is payable at 20 % per annum, semi-annually in cash or shares, at the option of each loan note holder. The Bridge Loan may be prepaid by the Company in whole (or in part), subject to payment of a minimum of six months' interest if prepaid within the first six months. The Company may redeem 50 % of the Bridge Loan without prepayment penalty by forcing a conversion into shares, provided that the shares are marginable and freely tradable on a liquid exchange, and provided further that, if such forced conversion is effected within six months from the date of the Bridge Loan, then the Company shall pay six month's interest on the unpaid and unconverted principal balance of the Bridge Loan immediately before such forced conversion (such interest being payable in cash or shares, at the option of each loan note holder).

 

 


11




 

 

Table of Contents

 

NOTE 6 - CONVERTIBLE NOTES PAYABLE  (continued)

 

For every $350 of principal amount of Bridge Loan advanced by MBTH, the loan note holder will be issued one warrant to subscribe one share at a subscription price of $0.35 per share. The warrants are exercisable for a period of five years from issuance. We agreed to pay an origination fee of 5% to note holders. We drew down an additional $ 80,000 on the Bridge Loan with MBTH and $ 690,000 with the other non-related investors from July 1, 2013 through July 18, 2013 to finance our operating activities for a total of $ 6,768,000 with MBTH and $ 2,267,300 with the other investors. Additionally, we accrued additional interest and fees of $ 475,000 from July 1, 2013 through July 18, 2013.

 

On July 18, 2013, we exercised our right to force a conversion of 50 % of the then outstanding principal balance under the Bridge Loan Agreement and received notification of intent to convert the remaining 49 % of the principal balance under the Bridge Loan and all accrued interest and fees from MBTH and other non-related investors that investors holding a total principal balance under the Bridge Loan of $ 8,910,000 and accrued interest and fees of approximately $ 1,355,000 .

 

On August 7, 2013, we repaid $ 125,000 to a non-related investor for investment into the Bridge Loan.

 

On August 22, 2013, we refinanced approximately $ 1,013,000 of liabilities previously paid by MBTH during 2013 on our behalf through the Bridge Loan and incurred an origination fee of approximately $ 50,000 . We received notification from MBTH of its intent to convert the principal balance and accrued fees and interest of $ 101,000 .

 

On August 22, 2013, we issued 2,187,529 common shares for the conversion of the balance of approximately $ 11,429,000 in principal and accrued interest and fees at a price per share of $ 5.225 . Because the Bridge Loan was convertible into new shares at 95 % of the price of any future equity financing, the Company recorded a charge of $ 0.6 million in interest expense during the three months September 30, 2013, due to the difference between the IPO price of $ 5.50 and $ 5.225 . Additionally, we issued warrants to purchase 1,093,778 underlying shares as additional consideration to the investors who exercised their conversion option. The warrants vested immediately and are exercisable into common shares at an exercise price of $ 6.87 per share and have a term of five years from the date of issuance. The Bridge Loan balance and accrued interest and fees were $ 0 as of September 30, 2013.

 

On August 22, 2013, the Company recorded an inducement charge of $ 1.8 million for the additional warrants to purchase 1,093,778 underlying shares as additional consideration to the investors who exercised their conversion option. The issuance of the warrants is considered an inducement to convert the Bridge Loan balance as the warrants were issued in addition to the common shares contractually required by the Bridge Loan Agreement. The charge was calculated using the fair market value of the warrant. As a result, the Company recorded during the three months ended September 30, 2013, an inducement expense of $ 0.4 million for 237,173 warrants given to non-related parties and a an inducement of $ 1.4 million to additional paid in capital for 856,605 warrants given to related parties.

 

Treco

On October 6, 2011, the Company entered into a convertible promissory note (the "$2 million Convertible Note") in favor of Treco International, S.A. ("Treco"), a related party, as part of the settlement compensation to Treco for terminating the infrastructure agreement. The $ 2 million Convertible Note is payable on final maturity, October 6, 2018 and is convertible, at Treco's option, into common shares of the Company at a price of $ 35.00 per share. Interest at the rate of 9 % per year is payable semi-annually in cash or shares, at the Company's option. As of September 30, 2013, $2 million of principal balance was outstanding under the $2 million Convertible Note. The accrued interest at September 30, 2013 was $ 87,000 and is reflected in the balance sheet as accrued interest and fees to related parties. On May 7, 2013, we issued 6,923 shares in repayment of $90,000 of interest.

 

 

 

 

 

 NOTE 7 - COMMITMENTS

 

 

 

The Company's office rental, deployment sites and warehouse facilities expenses aggregated approximately $ 218,000 and $ 207,000 of which approximately $ 74,000 and $ 119,000 was capitalized during the nine months ended September 30, 2013 and 2012, respectively. The leases will expire on different dates from 2014 through 2016 . Total minimum future annual rentals, exclusive of real estate taxes and related costs, are approximately as follows:

 

Twelve Months Ended September 30,





2014


$

307,000


2015



309,000


2016



201,000




$

817,000


 

 

 

 

 

 


12




 

 

 

 

 

 

Table of Contents

 

 NOTE 8 - RELATED PARTY TRANSACTIONS

 

MBTH

As of September 30, 2013 MBTH owned approximately 48.98 % of the Company's outstanding shares, which represents a controlling interest. The Company has entered into convertible notes with MBTH refer to Note 6 - Convertible Notes Payable.

 

Effective July 1, 2011, by agreement of a committee of the Directors who did not own interests in MBTH, the Company entered into an arrangement with MBTH whereby MBTH assumed certain liabilities of the Company including certain payroll, management fees and other operating costs in the amount of $ 250,000 per month for a period of twelve months. In consideration for this agreement, the Company issued MBTH 342,857 shares on June 23, 2011 at a price of $ 8.75 per share for proceeds of $ 3 million. On July 1, 2012 the agreement with MBTH to assume liabilities of the Company expired. Subsequent to the assumption of liability agreement and through September 30, 2013, MBTH paid additional liabilities on behalf of the Company amounting to $ 2.3 million. From January 1, 2013 through September 30, 2013, MBTH paid additional liabilities on the behalf of the Company of approximately $ 1,916,000, the Company repaid MBTH $ 675,000 for liabilities previously paid by MBTH, and the Company refinanced $ 1,013,000 of liabilities previously paid by MBTH into the Bridge Loan (see Note 6 - Convertible Notes Payable) for a net increase in the related party liability of $ 228,000 . The due to related party balance was $ 1,326,000 as of September 30, 2013.

 

On September 30, 2013, the independent directors of the Company authorized a onetime agreement, whereby we issued to MBTH 1,599,453 shares of our common stock and a warrant to purchase 1,363,636 shares of our common stock at an exercise price of $ 6.87 per share for the difference in price between the shares issued to them in March 2013 at a price of $ 13.30 per share in exchange for the conversion of its 2011 Convertible Note and the $ 5.50 purchase price for shares sold in our initial public offering in July 2013. Additionally, the Modified Strike Price, agreed upon between the Company and MBTH in January 2013, of $ 13.30 per share for the two options representing 571,428 underlying shares granted to MBTH in February 2011 has been lowered to $5.50. See Note 10 - Equity.

 

Mooers Branton & Co. Incorporated

On March 2, 2006, the Company entered into a management agreement (the "Management Agreement") with Mooers Branton & Co. Incorporated ("MBC"), a Florida corporation, pursuant to which MBC agreed to provide certain management and financial services to the Company for a monthly fee of $ 80,000. The Management Agreement was effective January 1, 2006. The Company incurred fees related to the Management Agreement of $ 720,000 for the nine months ended September 30, 2013 and 2012. MBC is beneficially controlled and operated by Rick Mooers and Roger Branton, a director and the Chief Financial Officer, respectively, of the Company.

 

Treco

See Note 6 - Convertible Notes Payable.

 

 

 

 

 

NOTE 9 - CONTINGENCIES

 

The Company is subject, from time to time, to claims by third parties under various legal theories. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company's liquidity, financial condition and cash flows. As of September 30, 2013, the Company did not have any legal actions pending.

 

 

 


13




 

 

 

 

Table of Contents

 

NOTE 10 - EQUITY

 

Initial Public Offering

On July 24, 2013, the Company closed its initial public offering of 1,337,792 shares of common stock, par value $ 0.00001 per share, and 668,896 warrants to purchase 668,896 shares of common stock, at a purchase price to the public of $ 5.50 per share and $ 0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts and offering expenses, of $ 6,750,673 . The warrant is to purchase 1 share of our common stock and will have an exercise price of $ 6.87 per share. The warrants are exercisable immediately and will expire five years from the date of issuance. The Company intends to use the offering for working capital and general corporate purposes. Feltl and Company and Aegis Capital Corp acted as joint underwriters for the offering.

 

Over-allotment Option

On August 19, 2013, the underwriters exercised in full their over-allotment option to purchase an additional 200,668 shares of common stock and 100,334 warrants to purchase 100,334 shares of common stock with an exercise price of $ 6.87 , at a purchase price to the public of $ 5.50 per share and $ 0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts, of $ 1,027,349 .

 

Issuance of Shares and Warrants to MBTH

 

On September 30, 2013, disinterested directors of the Company authorized a onetime agreement, whereby we issued to MBTH 1,599,453 shares of our common stock and a warrant to purchase 1,363,636 shares of our common stock at an exercise price of $ 6.87 per share for the difference in price between the shares issued to them in March 2013 at a price of $ 13.30 per share in exchange for the conversion of its 2011 Convertible Note and the $ 5.50 purchase price for shares sold in our initial public offering in July 2013. Additionally, the Modified Strike Price, agreed upon between the Company and MBTH in January 2013, of $13.30 per share for the two options representing 571,428 underlying shares granted to MBTH in February 2011 has been lowered to $5.50. In connection with the onetime agreement, we recorded a total of $ 10.1 million to Other expense, of which, $ 7.8 million was the fair market value of the 1,599,453 shares of common stock issued to MBTH; $ 1.8 million was the fair market value of the warrants to purchase 1,363,636 shares of common stock which were issued to MBTH; and $ 0.5 million was the change in the fair market value immediately before and after the modification of the stock price for options with 571,428 underlying shares.

 

Warrants and Options

The Company has issued warrants and options outside of the equity incentive plans. A summary of the warrant and option activity is as follows:

 

 



Number of Warrants
and Options (in Shares)


Weighted Average Exercise Price


Outstanding January 1, 2013



594,285


$

25.90


Granted



3,481,221



6.81


Exercised



-



-


Forfeited or Expired



-



-


Outstanding, September 30, 2013



4,075,506



6.69


Exercisable, September 30, 2013



4,075,506


$

6.69


 

The modification of the existing options with MBTH (refer to Note 6 - Convertible Notes Payable) was considered an induced conversion. The Company calculated the value of the options immediately prior to the amendment compared to the value of the option with the amended terms. The Company used the following assumptions in the Black Scholes Model to calculate the fair value of the warrants:

 



January 16, 2013




Original Terms



Amended Terms


Exercise price


$

17.50 $35.00



$

13.30


Volatility



140

%



140

%

Risk-free interest rate



0.27

%



0.27

%

Expected dividend yield



0

%



0

%

Expected term (years)



3




3


 

 


14




 

 

Table of Contents

 

NOTE 10 - EQUITY  (continued)

 

The Company agreed to award MBTH an option for 142,857 common shares with an exercise price equal to $ 8.75 per share. The warrants are exercisable for a period of five years from issuance and are fully vested on the date of issuance. The Company used the following assumptions in the Black Scholes model to calculate the fair value of the warrants:

 



January 16, 2013


 

Exercise price


$

8.75


Volatility



139.9

%

 

Risk-free interest rate



0.75

%

 

Expected dividend yield



0

%

 

Expected term (years)



5


 

 

The Company agreed to award MBTH an option for 42,857 common shares with an exercise price equal to $ 0.35 per share. The warrants are exercisable for a period of five years from issuance and are fully vested on the date of issuance. The Company used the following assumptions in the Black Scholes model to calculate the fair value of the warrants:

 



January 16, 2013


Exercise price


$

0.35


Volatility



137.7

%

Risk-free interest rate



0.88

%

Expected dividend yield



0

%

Expected term (years)



5.00


 

The Company agreed to modify the exercise price on two options representing 571,428 underlying common shares granted to MBTH under the February 2011 Convertible Loan from $13.30 to the Modified Strike Price of $5.50. The Company calculated the value of the options immediately prior to the amendment compared to the value of the option with the amended terms.

 



September 30, 2013


Exercise price


$

5.50


Volatility



109.8

%

Risk-free interest rate



0.13

%

Expected dividend yield



0

%

Expected term (years)



5.00


 

The risk-free rate is based on the rate for the U.S. Treasury note over the expected term of the warrants. The expected term is the full term of the warrant. Expected volatility is based on the average of the weekly share price changes over the shorter of the expected term or the period from the placement on AIM to the date of the grant.

 

For every $ 350 of principal amount of Bridge Loan advanced by a loan note holder, the loan note holder was issued a warrant for one underlying share with an exercise price of $ 0.35 per share. The warrants for 28,727 underlying shares are exercisable for a period of five years from issue and are fully vested on the date of issuance. The warrants were issued in connection with the Bridge Loan and were recorded as a debt discount of $ 401,000 against the Bridge Loan. The Company used the following weighted average assumptions in the Black Scholes model to calculate the fair value of the warrants:

 



Nine Months Ended
September 30, 2013


Exercise price


$

0.35


Volatility



104.4

%

Risk-free interest rate



0.68

%

Expected dividend yield



0

%

Expected term (years)



5.00


 

The Company agreed to award MBTH a warrant to purchase 1,363,636 shares of our common stock with an exercise price equal to $6.87 per share. The warrants are exercisable for a period of five years from issuance and are fully vested on the date of issuance. The Company used the trading price to calculate the fair value of the warrants.

 

 


15




 

 

 

 

 

 

 

Table of Contents 

 

 NOTE 11 - SUBSEQUENT EVENTS

 

Completion of Sale

On October 16, 2013, we completed the first delivery of our xMax comprehensive cognitive radio system, shipping equipment required to fulfill the $ 155,000 purchase order that was received from rural broadband provider Walnut Hill Telephone Company on November 26, 2012. Larry Townes is Chairman of Townes Tele-Communications, Inc., the parent company of Walnut Hill Telephone Company. Given that Larry Townes is a director of xG Technology, the sale of equipment to Walnut Hill Telephone Company is considered to be a related party transaction.

 

Bridge Financing

On October 22, 2013, we entered into a term sheet with a private investor (the "Investor") for the purchase of convertible promissory notes (the "Notes") for a minimum amount of $ 1.5 million and a maximum amount of $ 3 million (the "Bridge Financing"). The Notes will mature 12 months from the execution date and will have an interest rate of 12 %.The Notes will be convertible into shares of our common stock at the lower of $ 5.50 or, in the event we complete a qualified offering, at 85 % of the price of such offering. We may redeem the outstanding principal and interest at 130 %. In the event we complete a qualified offering, we will retire 50 % of the then principal outstanding.

 

The Notes are subject to the completion of a definitive agreement (the "Definitive Agreement") which will include customary closing conditions and other customary provisions including event of defaults and anti-dilution rights. Should we fail to enter into a Definitive Agreement because we chose alternative financing, we will pay the Investor $ 50,000 as a breakup fee.

 

Aegis Capital Corp. is the Placement Agent for the Financing and will receive a cash commission of 8 % of the funds raised.

 

Pricing of Public Offering

 

On November 12, 2013, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Aegis Capital Corp. and Feltl and Company (the "Underwriters"), pursuant to which the Company agreed to sell, and the Underwriters agreed to purchase for resale to the public (the "Offering"), subject to the terms and conditions expressed therein, an aggregate 5,715,000 shares of common stock, par value $ 0.00001 per share (the "Shares"), at a price to the public of $ 1.75 per share, for an aggregate of approximately $ 10,000,000 in gross proceeds less underwriting discounts and commissions.   In addition, the Company granted the Underwriters a 45-day option to purchase up to an additional 856,428 Shares to cover over-allotments, if any.

 

The Company expects the Offering to close on or about November 18, 2013, subject to the satisfaction of customary closing conditions.   The Underwriting Agreement provides that the Company will indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended, or to reimburse the Underwriters for payments that the Underwriters may be required to make because of such liabilities.

 

 


16




 

 

 

 

 

 

 

 

 

 

Table of Contents

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

 

Cautionary Notice Regarding Forward Looking Statements

 

The information contained in Item 2 contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Actual results may materially differ from those projected in the forward-looking statements as a result of certain risks and uncertainties set forth in this report. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual results will not be different from expectations expressed in this report.

 

This filing contains a number of forward-looking statements which reflect management's current views and expectations with respect to our business, strategies, products, future results and events, and financial performance. All statements made in this filing other than statements of historical fact, including statements addressing operating performance, events, or developments which management expects or anticipates will or may occur in the future, including statements related to distributor channels, volume growth, revenues, profitability, new products, adequacy of funds from operations, statements expressing general optimism about future operating results, and non-historical information, are forward looking statements. In particular, the words "believe," "expect," "intend," "anticipate," "estimate," "may," variations of such words, and similar expressions identify forward-looking statements, but are not the exclusive means of identifying such statements, and their absence does not mean that the statement is not forward-looking. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below. Our actual results, performance or achievements could differ materially from historical results as well as those expressed in, anticipated, or implied by these forward-looking statements. We do not undertake any obligation to revise these forward-looking statements to reflect any future events or circumstances.

 

Readers should not place undue reliance on these forward-looking statements, which are based on management's current expectations and projections about future events, are not guarantees of future performance, are subject to risks, uncertainties and assumptions (including those described below), and apply only as of the date of this filing. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, the risks to be discussed in our initial Registration Statement on Form S-1, declared effective by the Securities and Exchange Commission on July 18, 2013 ("Form S-1"), and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

 

The share numbers in the following discussion reflect a 1-for-25 reverse stock split that we effected March 24, 2013 as well as the 1-for-1.4 reverse stock split that we effected March 28, 2013.

 

Overview

 

xG Technology, Inc. ("xG", the "Company", "we", "our", "us") has developed a broad portfolio of innovative intellectual property that we believe will enhance wireless communications. Our intellectual property is embedded in proprietary software algorithms that offer cognitive interference mitigation and spectrum access solutions.

 

Our strategy is initially to commercialize our intellectual property portfolio by developing and selling network equipment using our proprietary software algorithms to offer cognitive interference mitigation and spectrum access solutions. In the future, our strategy is for our intellectual property to be embedded by partners in a semiconductor chip that could be sold to third party equipment manufacturers and inserted in their devices and to license our intellectual property to other customers in vertical markets world-wide. Our technology roadmap currently projects this transition to begin in 2015.

 

 


17




 

 

Table of Contents

 

The implementation of our cognitive radio intellectual property is xMax®. We believe the xMax® system, represents the only commercially available cognitive radio network system that is designed to include interference mitigation by spatial processing. xMax® implements our proprietary interference mitigation software that can increase capacity on already crowded airwaves by improving interference tolerance, enabling the delivery of a comparatively high Quality of Service where other technologies would not be able to cope with the interference.

 

We believe that the xMax® system will also, when in a future development operating on more than one radio channel, deliver dynamic spectrum access by scanning and finding unused or underused frequencies (unlicensed as well as licensed) and dynamically tuning to them, significantly increasing their usable capacity.

 

Our system is frequency agnostic although currently designed to operate within the 902 - 928 MHz license-free band. xMax® is intended to serve as a mobile voice over internet protocol ("VoIP") and broadband data system that utilizes an end-to-end Internet Protocol ("IP") system architecture. The xMax® product and service suite includes a line of access points, network bridges, mobile switching centers, network management systems, deployment tools, and customer support. The xMax® system will allow mobile operators to utilize free, unlicensed 902 - 928 MHz ISM band spectrum (which spectrum is available in most of the Americas) instead of purchasing scarce expensive licensed spectrum. Our xMax® system will also enable enterprises to set up a mobile communications network in an expeditious and cost effective manner. In addition, we believe that our xMax® cognitive radio technology can also be used to provide additional capacity to licensed spectrum by identifying and utilizing unused bandwidth within the licensed spectrum.

 

Plan of Operations

 

We are executing on our sales and marketing strategy and have entered into agreements both direct with end-customers as well as with indirect channel network partners. These customer engagements primarily relate to two of our target markets in rural telecommunications and defense. Together, they comprise commitments to purchase xMax® cognitive radio networking equipment, engineering services and other hardware worth approximately $35.4 million.

 

As of September 30, 2013, the new product line that can handle both voice and data services became available. These new products are called xAP (base station), xMod and xVM. The latter two are able to communicate to any commercial off the shelf device.

 

 


18




 

 

Table of Contents

 

Results of Operations

 

Comparison for the three and nine months ended September 30, 2013 and 2012

 

Revenues

 

Revenues for the three and nine months ended September 30, 2013, were $33,000 and $33,000, respectively, representing an increase of $33,000 and $33,000, respectively, from $0 and $0 in the corresponding periods in 2012. The revenue of $33,000 resulted from a service based consulting agreement with one of our customers during the three months ended September 30, 2013.

 

Cost of Revenue and Operating Expenses

 

Cost of Components and Personnel

Cost of components and personnel for the three and nine months ended September 30, 2013, were $1,000 and $1,000, representing an increase of $1,000 and $1,000, respectively, from $0 and $0 in the corresponding periods in 2012. Cost of components and personnel of $1,000 is based on the cost of the time allocated towards the consulting agreement during the three months ended September 30, 2013.

 

General and Administrative Expenses

General and administrative expenses are the expenses of operating the business on a daily basis and include salary and benefit expenses and payroll taxes, as well as the costs of trade shows, marketing programs, promotional materials, professional services, facilities, general liability insurance, and travel. For the three and nine months ended September 30, 2013, the Company incurred aggregate expense of $1.9 million and $4.4 million, respectively, compared to $1.3 million and $3.9 million, respectively, for the three and nine months ended September 30, 2012, representing an increase of $0.6 million or 53% for the three months and an increase of $0.5 million or 14% for the nine months. The increase is due to an increase in consulting fees associated with the Company's listing on NASDAQ.

 

Development Expenses

Development expenses consist primarily of salary and benefit expenses and payroll taxes, as well as costs for prototypes, facilities and travel. Development expenses increased $0.6 million, or 53%, from $1.2 million in the three months ended September 30, 2012 to $1.8 million in the three months ended September 30, 2013. Development expenses increased $1.7 million or 56%, from $3.1 million in the nine months ended September 30, 2012 to $4.8 million in the nine months ended September 30, 2013. The increases are due to additional costs related to producing and testing equipment as the Company's products became available for sale on September 30, 2013.

 

Stock Based Compensation

Stock based compensation increased $0.05 million, from $0.15 million in the three months ended September 30, 2012 to $0.2 million in the three months ended September 30, 2013. Stock based compensation increased $0.28 million, from $0.26 million in the nine months ended September 30, 2012 to $0.54 million in the nine months ended September 30, 2013. The increase arose from the increase in the number of employees and directors of the Company who received option grants in fiscal 2013.

 

Amortization and Depreciation

Amortization and depreciation expenses decreased $0.1 million, or 14%, from $0.5 million in the three months ended September 30, 2012 to $0.4 million in the three months ended September 30, 2013, and $0.2 million, or 15% from $1.5 million in the nine months ended September 30, 2012 to $1.3 million in the nine months ended September 30, 2013. The decrease was primarily due to the decrease in the depreciation of our property and equipment as a portion of our assets became fully depreciated during 2013.

 

Other

Inducement expense for the three months ended September 30, 2013 was $0.4 million compared to $0.0 million for the three months ended September 30, 2012, an increase of $0.4 million. Inducement expense for the nine months ended September 30, 2013 was $0.4 million compared to $0.0 million for the nine months ended September 30, 2012, an increase of $0.4 million. The increase was due to the warrants given to non-related parties in relation with the conversion of the Bridge Loan.

 

Interest expense for the three months ended September 30, 2013 was $1.1 million compared to $0.2 million for the three months ended September 30, 2012, an increase of $0.9 million or 654%. Interest expense for the nine months ended September 30, 2013 was $2.2 million compared to $0.3 million for the nine months ended September 30, 2012, an increase of $1.9 million or 531%. The increase was due to the higher interest and fees incurred on the Bridge Loan for 2013 compared to the May 2011 Convertible note in 2012; the fee was amortized over a shorter period of one year based on the contractual obligation of the Bridge Loan; $0.4 million from the accretion of the debt discount recorded as interest expense; and $0.6 million in interest expense resulted from the Bridge Loan being convertible into new shares at 95% of the price of any future equity financing due to the difference between the IPO price of $5.50 and $5.225 in 2013.  

 

 


19




 

 

Table of Contents

 

Other expense for the three and nine months ended September 30, 2013, was $10.1 million and $10.1 million, respectively, representing an increase of $10.1 million and $10.1 million, respectively, from $0 and $0 in the corresponding periods in 2012. The increase of $10.1 million is a result of the independent directors of the Company authorizing a onetime agreement on September30, 2013, whereby we issued to MBTH 1,599,453 shares of our common stock and a warrant to purchase 1,363,636 shares of our common stock at an exercise price of $6.87 per share for the difference in price between the shares issued to them in March 2013 at a price of $13.30 per share in exchange for the conversion of its 2011 Convertible Note and the $5.50 purchase price for shares sold in our initial public offering in July 2013. Additionally, the Modified Strike Price, agreed upon between the Company and MBTH in January 2013, of $13.30 per share for the two options representing 571,428 underlying shares granted to MBTH in February 2011 has been lowered to $5.50.

 

Net Loss

 

For the three months and nine months ended September 30, 2013, the Company had a net loss of $15.9 million and $23.7 million, respectively, as compared to a net loss of $3.2 million and $9.1 million for the three and nine months ended September 30, 2012, or an increase of $12.7 million and $14.6 million, respectively. The increase in net loss is due mainly to the increase in development expenses, interest expenses and other expenses discussed above.

 

Liquidity and Capital Resources

 

Our operations primarily have been funded through cash generated by financing. During the first nine months 2013, the Company relied upon additional investment through proceeds from the IPO, Bridge Loan and convertible notes payable.

 

To date, we have financed our operations primarily through the sale of equity and convertible debt. As of September 30, 2013, the Company has negative working capital of approximately $2.6 million and $2.6 million of cash and cash equivalents.

 

We have incurred net losses of $15.9 million and $3.3 million in the three months ended September 30, 2013 and 2012, respectively. Additionally, we have incurred negative operating cash flows including cash used in operations of $8.2 million and $4.2 million in the nine months ended September 30, 2013 and 2012, respectively.

 

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth, the timing and extent of spending to support development efforts, the timing of new product introductions, market acceptance of our products and overall economic conditions. The Company does not currently have sufficient capital in order to achieve cash flow breakeven. Therefore, the Company is actively evaluating various alternatives of financing in order to obtain additional capital to allow the Company to deliver its products and fulfill its current backlog.

 

Please see Note 11 - Subsequent Events in our financial statements for a discussion of our recent activities related to our efforts to raise additional capital subsequent to September 30, 2013.

 

Initial Public Offering

 

On July 24, 2013, the Company closed its initial public offering of 1,337,792 shares of common stock, par value $0.00001 per share, and 668,896 warrants to purchase 668,896 shares of common stock, at a purchase price to the public of $5.50 per share and $0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts and offering expenses, of $6,750,673. The warrant is to purchase 1 share of our common stock and will have an exercise price of $6.87 per share. The warrants are exercisable immediately and will expire five years from the date of issuance. The Company intends to use the offering for working capital and general corporate purposes. Feltl and Company and Aegis Capital Corp acted as joint underwriters for the offering.

 

Over-allotment Option

 

On August 19, 2013, the underwriters exercised in full their over-allotment option to purchase an additional 200,668 shares of common stock and 100,334 warrants to purchase 100,334 shares of common stock with an exercise price of $6.87, at a purchase price to the public of $5.50 per share and $0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts, of $1,027,349.

 

Bridge Loan

 

On August 7, 2013, the Company repaid $125,000 to a non-related investor for investment into the Bridge Loan.

 

During the first nine months of 2013, the Company drew down $5.0 million under the Bridge Loan. On August 22, 2013, the Company refinanced approximately $1,013,000 of liabilities previously paid by MBTH during 2013 on behalf of the Company through the Bridge Loan and incurred an origination fee of approximately $50,000. The Company received notification from MBTH of its intent to convert the principal balance and accrued fees.

 

 


20




 

 

Table of Contents

 

On August 22, 2013, the Company issued 2,187,529 common shares for the conversion of the balance of approximately $11,429,000 in principal and accrued interest and fees at a price per share of $5.225. Because the Bridge Loan was convertible into new shares at 95% of the price of any future equity financing, the Company recorded a charge of $0.6 million in interest expense during the three months September 30, 2013, due to the difference between the IPO price of $5.50 and $5.225. Additionally, the Company issued warrants to purchase 1,093,778 underlying shares as additional consideration to the investors who exercised their conversion option. The warrants vested immediately and are exercisable into common shares at an exercise price of $6.87 and have a term of five years from the date of issuance. The issuance of the warrants is considered an inducement to convert the Bridge Loan balance as the warrants were issued in addition to the common shares contractually required by the Bridge Loan Agreement. The Bridge Loan balance and accrued interest and fees was $0 as of September 30, 2013.

 

Convertible Notes Payable

 

During the first nine months of 2013, the Company drew down $450,000 under the convertible notes payable to related party, compared to $7.5 million during the first nine months of 2012.

 

 


21




 

 

Table of Contents

 

Cash Flows

 

The following table sets forth the major components of our statements of cash flows data for the periods presented.

 

For the Nine Month Period Ended

(In Thousands)

 



September 30,
2013


September 30,
2012


Cash flows used in Operations


$

(8,241)


$

(4,233)










Investing Activities


$

(2,569)


$

(3,674)










Financing Activities


$

13,097


$

7,920










Cash at end of period


$

2,558


$

146


 

Operating Activities

 

Net cash used in operating activities for the nine months ended September 30, 2013 totaled $8.2 million as compared to $4.3 million for the nine months ended September 30, 2012. The cash used in operating activities consisted principally of the net loss from operations.

 

Investing Activities

 

Net cash used in investing activities for the nine months ended September 30, 2013 was $2.6 million as compared to $3.7 million for the nine months ended September 30, 2012. The represents capital expenditures primarily associated with the investment in product and technology development and our patent portfolio.

 

Financing Activities

 

Our net cash provided by financing activities for the nine months ended September 30, 2013 was $13.1 million as compared to $7.9 million for the nine months ended September 30, 2012, which primarily consisted of proceeds from further advances under convertible promissory notes issued by the Company and proceeds from issuance of common stock. The Company raised $7.8 million through the IPO and IPO over allotment, drew down $5.0 million under the Bridge Loan and $0.5 million under the convertible notes payable to related party during the first nine months of 2013. Also MBTH converted their promissory note of $15 million and issued additional proceeds of $5.4 million under the Bridge Loan during the first nine months of 2013.

 

 


22




 

 

Table of Contents

 

Off-Balance Sheet Arrangements

 

We do not currently have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

Our Company has not entered into any transaction, agreement or other contractual arrangement with an entity unconsolidated with us under which we have:

 

o

an obligation under a guarantee contract, although we do have obligations under certain sales arrangements including purchase obligations to vendors;  

o

a retained or contingent interest in assets transferred to the unconsolidated entity or similar arrangement that serves as credit, liquidity or market risk support to such entity for such assets;

o

any obligation, including a contingent obligation, under a contract that would be accounted for as a derivative instrument; or

o

any obligation, including a contingent obligation, arising out of a variable interest in an unconsolidated entity that is held by us and material to us where such entity provides financing, liquidity, market risk or credit risk support to, or engages in leasing, hedging or research  and development services with us.

 

 


23




 

 

Table of Contents

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 

 

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.

 

Item 4.  Controls and Procedures. 

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), does not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 
During the quarter ended September 30, 2013, we carried out an evaluation, under the supervision and with the participation of our management, including the principal executive officer and the principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13(a)-15(e) under the Exchange Act. Based on this evaluation, because of the identification of a control deficiency described below, management concluded that as of September 30, 2013, our disclosure controls and procedures were not effective.
 
In conjunction with our recent initial public offering in the United States, which occurred in our current quarter, we recently switched over from financial reporting in IFRS to U.S. generally accepted accounting principles. Our management has previously identified a control deficiency regarding inadequate accounting resources due to the need to hire accounting personnel with the requisite knowledge of U.S. generally accepted accounting principles. While we have now hired a financial controller to support the accounting personnel, the financial controller began with less than one month before the end of the quarter ended September 30, 2013 and had limited involvement with the disclosure controls and procedures for this quarter. The accounting department is now in the process of cross training, putting in place additional accounting policies and controls to resolve the issues previously described.

 

Management believes that the hiring of that additional person who has the technical expertise and knowledge with the non-routine or technical issues we have previously encountered will result in both proper recording of these transactions and a more knowledgeable finance department as a whole. The accounting staff are providing the cross training needed to support us if personnel turn over issues within the department occur. We believe this will greatly decrease any control and procedure issues we may encounter in the future.
 

Changes in Internal Controls

 

During the fiscal quarter ended September 30, 2013, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

 


24




 

 

Table of Contents

 

PART II: OTHER INFORMATION

 

Item 1.  Legal Proceedings

 

From time to time, we are a party to litigation and subject to claims incident to the ordinary course of business. Future litigation may be necessary to defend ourselves and our customers by determining the scope, enforceability and validity of third party proprietary rights or to establish our proprietary rights.

 

As of September 30, 2013, we do not have any litigation matters pending.

 

Item 1A.   Risk Factors.

 

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

 

Unregistered Sales of Securities

 

On August 22, 2013, the Company issued 2,187,529 common shares for the conversion of the balance of approximately $11,429,000 in principal and accrued interest and fees at a price per share of $5.225. Additionally, the Company issued warrants to purchase 1,093,778 underlying shares as additional consideration to the investors who exercised their conversion option. The warrants vested immediately and are exercisable into common shares at an exercise price of $6.87 and have a term of five years from the date of issuance.

 

On September 30, 2013, the disinterested directors of the Company authorized a onetime agreement, whereby we issued to MBTH 1,599,453 shares of our common stock and a warrant to purchase 1,363,636 shares of our common stock at an exercise price of $6.87 per share for the difference in price between the shares issued to them in March 2013 at a price of $13.30 per share in exchange for the conversion of its 2011 Convertible Note and the $5.50 purchase price for shares sold in our initial public offering in July 2013. Additionally, the Modified Strike Price, agreed upon between the Company and MBTH in January 2013, of $13.30 per share for the two options representing 571,428 underlying shares granted to MBTH in February 2011 was lowered to $5.50.

 

The above issuances were made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and/or Rule 506 promulgated under Regulation D there under. The holders of the above securities are accredited investors as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.

 

Use of Proceeds

 

On July 24, 2013, we completed our initial public offering, pursuant to a Registration Statement on Form S-1 under the Securities Act of 1933, as amended (File No. 333-187094) (the "Registration Statement") that was declared effective by the Securities and Exchange Commission on July 18, 2013. Under the Registration Statement, we registered the offering and sale of 1,337,792 shares of common stock, par value $0.00001 per share, and 668,896 warrants to purchase 668,896 shares of common stock, at a purchase price to the public of $5.50 per share and $0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts and offering expenses, of $6,750,673. On August 19, 2013, the underwriters exercised in full their over-allotment option to purchase an additional 200,668 shares of common stock and 100,334 warrants to purchase 100,334 shares of common stock with an exercise price of $6.87, at a purchase price to the public of $5.50 per share and $0.01 per warrant, for net proceeds to the Company, after deducting underwriter discounts, of $1,027,349. Feltl and Company and Aegis Capital Corp acted as joint underwriters for the offering.

   

No payments for our expenses were made directly or indirectly to (i) any of our directors, officers or their associates, (ii) any person(s) owning 10% or more of any class of our equity securities or (iii) any of our affiliates with the funds raised in the offering, which funds we have not yet officially accepted or used to date.

 

There has been no material change in the planned use of proceeds from our offering as described in our final prospectus filed with the SEC pursuant to Rule 424(b).

 

Item 3.  Defaults Upon Senior Securities.

 

None.

 

Item 4.  Mine Safety Disclosures.

 

Not applicable.

 

Item 5.  Other Information.

 

There have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors.

 

 


25




 

 

Table of Contents

 

Item 6. Exhibits 

 

Exhibit

Number


Description  

31.1


Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.  

31.2


Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.  

32.1


Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.  

32.2


Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.  

101.INS *


XBRL Instance Document

101.SCH *


XBRL Taxonomy Schema

101.CAL *


XBRL Taxonomy Calculation Linkbase

101.DEF *


XBRL Taxonomy Definition Linkbase

101.LAB *


XBRL Taxonomy Label Linkbase

101.PRE *


XBRL Taxonomy Presentation Linkbase




 

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

 

* XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 


26




 

 

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 


xG TECHNOLOGY, INC.






Date: November 14, 2013

By:

/s/ John C. Coleman


 



John C. Coleman


 



Chief Executive Officer

(Duly Authorized Officer and Principal Executive Officer)


 





 

Date: November 14, 2013

By:

/s/ Roger G. Branton


 



Roger G. Branton


 



Chief Financial Officer

(Duly Authorized Officer and Principal Financial Officer)


 

 

 


27




 

 

Table of Contents

 

EXHIBIT INDEX

 

Exhibit

Number


Description

 

31.1


Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2


Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1


Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

32.2


Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS *


XBRL Instance Document

101.SCH *


XBRL Taxonomy Schema

101.CAL *


XBRL Taxonomy Calculation Linkbase

101.DEF *


XBRL Taxonomy Definition Linkbase

101.LAB *


XBRL Taxonomy Label Linkbase

101.PRE *


XBRL Taxonomy Presentation Linkbase




 

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

 

* XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 


28




 

 

 

 

 

 

 

 

 

Exhibit 31.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, John C. Coleman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of xG Technology, Inc. (the "registrant"):

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)        Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)        Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)        Evaluated the effectiveness of the registrant's disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d)        Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a)        All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b)        Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14 , 2013

/s/ John C. Coleman


John C. Coleman


Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

 

 

Exhibit 31.2

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Roger G. Branton, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of xG Technology, Inc. (the "registrant"):

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)        Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)        Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)        Evaluated the effectiveness of the registrant's disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

 

d)        Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a)        All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b)        Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14 , 2013

/s/ Roger G. Branton


Roger G. Branton


Chief Financial Officer

(Principal Financial Officer)

 

 

 

 

 

 

 

 

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U. S. C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of xG Technology, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2013 (the "Report"), I, John C. Coleman, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.          The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14 , 2013

/s/ John C. Coleman


John C. Coleman


Chief Executive Officer

(Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed from within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

 

 

 

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U. S. C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of xG Technology, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2013 (the "Report"), I, Roger G. Branton, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.          The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

 

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14 , 2013

/s/ Roger G. Branton


Roger G. Branton


Chief Financial Officer

(Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed from within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTLIFVALLLELIV

a d v e r t i s e m e n t